Diagnosis of Periprosthetic Joint Infection and the Common Pathogens, Durg-resistance in Periprosthetic Joint Infection

December 2, 2017 updated by: Lin Jianhao, Peking University People's Hospital
This retrospective study aims to improve the diagnosis of PJI as well as to identify microorganisms causing periprosthetic joint infection (PJI) and the drug-resistant spectrum

Study Overview

Detailed Description

160 patients who underwent revision or re-revision total hip or knee arthroplasty for different reasons in our institution were recruited from August 2013 to August 2016. 80 patients meet the criteria of PJI from the muscle and skeletal muscle Association (MSIS) are divided to the infection group, another 80 patients are divided into the non-infection group.

Medical and demographic data were recorded. Collected lab examinations included blood routine test, C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), synovial leukocyte counts, Receiver Operating Characteristic Curve-Area Under Curve (ROC-AUC) analysis will be used to evaluate the specific and sensitivity of diagnosis index. Moreover,microorganisms isolated from periprosthetic tissues and articular fluid. Postoperatively, the prosthesis was sent for ultrasound sonication. The sonicate extraction, implant surrounding tissue and synovium were sent for microbiologic culture, and the implant-surrounding-tissue were also sent for pathological examination. The isolated strains and drug-resistance rate for each bacterium for different antibiotics were presented.

Study Type

Observational

Enrollment (Anticipated)

160

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

50 years to 70 years (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Patient who underwent revision or re-revision total hip or knee arthroplasty for different reasons in our institution

Description

Inclusion Criteria:

  • patient who underwent revision or re-revision total hip or knee arthroplasty for different reasons in our institution

Exclusion Criteria:

  1. Patients who refused to join the trial group;
  2. Revision total hip/knee replacement for periprosthetic fracture;
  3. patients who missed some of important examination;
  4. Revision total hip/knee replacement for metal sensitivity;
  5. Revision total hip/knee replacement for the last period of second-stage revision;
  6. Patient who underwent revision with RA or other inflammatory disease.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
infectious group
Patients who met the criteria according of Periprosthetic Joint Infection were identified as the infectious group.
Periprosthetic Joint Infection is diagnosed according to the diagnosing criteria from the Workgroup of the Musculoskeletal Infection Society.
non-infectious group
Patients who didn't meet the criteria according of Periprosthetic Joint Infection were identified as the non-periprosthetic joint infection group.
PJI can not be diagnosed for the lack of clinical evidence according to the diagnosing criteria from the Workgroup of the Musculoskeletal Infection Society.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Evaluation the specific and sensitivity of CRP
Time Frame: within 4 weeks before the operation
To test the specifity and sensitivity of CRP
within 4 weeks before the operation
Evaluation the specific and sensitivity of ESR
Time Frame: within 4 weeks before the operation
To test the specifity and sensitivity of ESR
within 4 weeks before the operation
Evaluation the specific and sensitivity of synovial leukocyte counts
Time Frame: within 4 weeks before the operation
To test the specifity and sensitivity of synovial leukocyte counts
within 4 weeks before the operation

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Microorganisms identification and the
Time Frame: within 4 weeks before the operation
Identify microorganisms causing periprosthetic joint infection (PJI) as well as the drug-resistant spectrum.
within 4 weeks before the operation
Drug-resistant spectrum.
Time Frame: within 4 weeks before the operation
Identify the drug-resistant spectrum of the microorganisms.
within 4 weeks before the operation

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Jianhao Lin, arthritis and clinic and research center

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ANTICIPATED)

January 1, 2018

Primary Completion (ANTICIPATED)

December 1, 2019

Study Completion (ANTICIPATED)

December 1, 2019

Study Registration Dates

First Submitted

November 25, 2017

First Submitted That Met QC Criteria

December 2, 2017

First Posted (ACTUAL)

December 7, 2017

Study Record Updates

Last Update Posted (ACTUAL)

December 7, 2017

Last Update Submitted That Met QC Criteria

December 2, 2017

Last Verified

December 1, 2017

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • PKUPHACRC3

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Arthropathy of Knee

Clinical Trials on Periprosthetic Joint Infection

3
Subscribe